TOCQUEVILLE ASSET MANAGEMENT L.P. - DURATA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$761,000
-18.8%
60,000
+9.1%
0.01%
-11.1%
Q2 2014$937,000
+33.9%
55,000
+5.8%
0.01%0.0%
Q1 2014$700,000
-24.0%
52,000
-27.8%
0.01%
-25.0%
Q4 2013$921,000
+33.9%
72,000
-5.4%
0.01%
+33.3%
Q3 2013$688,000
+51.5%
76,100
+20.6%
0.01%
+50.0%
Q2 2013$454,00063,1000.01%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders